8% Compound Premixed Feed for Late Growing-Finishing

Name: 8% Compound Premixed Feed for Late Growing-Finishing
Brand: Shanghai Ganglu Huinong Biotechnology Co., Ltd.
SKU: 2139682382

Henan, ChinaShanghai Ganglu Huinong Biotechnology Co., Ltd.

US$1.50

100-999 kg

US$1.45

1,000-99,999 kg

US$1.40

100,000+ kg

Product profile

Customization

Available

Varieties

Chicks

Component

Vitamins

Model NO.

Y-13

Type

The First Class

Pharmacodynamic Influential Factors

Promote Development

Storage Method

Moisture Proof

Veterinary Reg. No.

N/a

Product Name

Florfenicol Injection 30%

Grade

Pharmaceutical Grade

Manufacture

Yes

SGS

Yes

Certificate

GMP

Sample

Avaliable

MOQ

100bottles

Transport Package

80 or 100glass Bottles/Carton

Specification

10ml, 20ml, 50ml, 100ml/OEM available

Trademark

Gangluhuinong, OEM, ODM

Origin

Henan China

HS Code

29322090

Production Capacity

500000L/Month

Company profile

High Repeat Buyers ChoiceOEM ServicesStandardized quality controlR&D Capabilities

Shanghai Ganglu Huinong Biotechnology Co., Ltd.

Henan, China

Business Type: Manufacturer/Factory, Group CorporationExport Year: 2006-06-08Nearest Port: qingdao, ShanghaiAverage Response Time: ≤9.04hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB, EXW, CFR, CIF, DDP, CIP, CPT, FCA

AI-Powered supplier vetting

SummaryThe supplier operates multiple production lines covering powder, injection, premix, oral liquid, and bio-additive products, and provides development, production, sales, and after-sales services. It reports OEM and ODM availability, full customization, two production lines, defined output for aquaculture and related products, and 21–30 R&D engineers. ISO 9001 and GMP certifications are stated. Manufacturing contracts and inventory capacity are available, while overseas warehouse and showroom services are not. Customer complaint handling and corrective/preventive action procedures are documented and followed, but the supplier reports no quality assurance in its quality control processes. Financial records are referenced for 2021–2023, but the provided information does not include assessable financial results. No customer cases are provided.

Supplier typeThe supplier is a manufacturer involved in product development, production, sales, and after-sales service, with production lines for powder, injection, premix, oral liquid, and bio-additives. Its stated focus includes traditional Chinese medicine fermentation and agricultural products, supported by a physical factory location and two operating production lines.

CertificationsThe supplier explicitly reports ISO 9001 and GMP certification of its management systems. These stated certifications provide direct evidence of certification holdings.

After-Sales capabilityThe company states that it provides after-sales service, has inventory capacity, and maintains documented procedures and followed records for customer complaints and corrective/preventive actions. However, it lacks overseas warehouse and overseas showroom capabilities, so the evidence supports after-sales processes but not broad overseas service infrastructure.

R&D capabilityThe supplier reports ODM service availability, a technological-innovation orientation, and 21–30 total R&D engineers. However, it has no available SDK, and the provided information does not quantify R&D facilities, patents, or product-development results; the evidence is positive but partial.

Production capacityThe supplier reports multiple product-specific production capabilities, two operating production lines, stated annual outputs for aquaculture products, growth promoters, and egg production enhancers, valid manufacturing contracts with associated subcontractors, and in-stock capacity. These details explicitly support production capability, although overseas warehousing is unavailable.

Customization capabilityThe supplier explicitly offers full customization and ODM services, and also provides OEM services for well-known brands. This directly demonstrates product and design customization capability.